Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1997-01-31
1999-12-28
Campbell, Eggerton A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 721, 436 64, C12Q 102, G01N 33567, G01N 3348
Patent
active
060080078
ABSTRACT:
The present invention provides a novel method for assaying radiation resistance of cancer cells by isolating cancer cells, irradiating the cells, incubating the cells with a labeled marker indicative of cell proliferation, measuring the amount of labeled marker incorporated into the cells in order to determine the effect of radiation on the proliferation of cells, and then determining the relative resistance of the cells to radiation. Also provided are methods of assaying radiation resistance of cancer cells which are exposed to radiation and radio-sensitzing or chemotherapeutic agents.
REFERENCES:
Lokeshwar et al., "Enhancement of radiation response of prostatic carcinoma by Taxol: Therapeutic potential for late-stage malignancy" Anticancer Res. (1995) 15(1):93-98.
Hennequin et al., "Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells" Cancer Res. (1996) 56(8):1842-1850.
Edelstein et al. "Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer" Semin. Oncol. (1996) 23(2 Suppl. 5):41-47.
Silver et al., "Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line" Cancer (1996) 77(9):1850-1853.
Kosary, "FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina" Surgical Oncology (1994) 10:31-46.
Lanciano et al., "Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies" International J. Radiation Oncology (1991) 20:667-676.
Ruka et al., "Comparison between the in vitro intrinsic radiation sensitivity of human soft tissue sarcoma and breast cancer cell lines" J. Surg. Oncol. (1996) 61(4):290-294.
Ma et al., "Heterogeneity in radiosensiivity of human diploid fibroblasts from keloids and normal skins" Cell Biol. Int. (1996) 20(4):289-292.
Ramsay et al., "Normal tissue radiosensitivity in breast cancer patients" Int. J. Radiation Oncology (1995) 31(2):339-344.
Taghian et al., "In vivo radiation sensitivity of glioblastoma multiforme" Int. J. Radiat. Oncol. Biol. Phys. (1995) 32(1):99-104.
Zaffaroni et al., "Lack of a correlation between p53 protein expression and radiation response in human tumor primary cultures" Stem Cells (1995) 13:77-85.
Bristow et al., "P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection" Int. J. Radiat. Oncol. Biol. Phys. (1996) 34(2):341-355.
Griffon et al., "Radiosensitivity of multicellular tumour spheroids obtained from human ovarian cancers" European J. Cancer (1995) 31A(1):85-91.
Dunst et al. "Kann man extrem erhohte strahlensensitivitat von patienten durch in-vitro-testung von lymphozyten erkennen?" Strahlenther Onkol. (1995) 171(10):581-586. (English abstract is on pp. 581-582).
West et al., "Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix" (1993) British J. Cancer 68:819-823.
Burger et al., "In vitro radiation response assay for cervical carcinoma: Evidence for radiosensitization and cervical implications" Proc. Soc. Gynecol. Oncol. (1996) 1 page total.
Kern et al., "Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures" J. Natl. Cancer Inst. (1990) 82:582-588.
Fruehauf et al., "In vitro determination of drug response: A discussion of clinical applications" Principles & Practice of Oncology. PPO Updates (1993) 7(12):1-16.
Brunet et al, Acta Oncologica 34(7):941-944, 1995.
Levin et al, Cancer Treatment Reports 70(6):739-743, 1986.
Fruehauf John P.
Parker Ricardo J.
Campbell Eggerton A.
Oncotech, Inc.
LandOfFree
Radiation resistance assay for predicting treatment response and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiation resistance assay for predicting treatment response and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiation resistance assay for predicting treatment response and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2381465